Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Brent Babcock Discusses New CRISPR IP Alliance

December 19, 2016  | Brenton R. Babcock

Partner Brent Babcock, Chair of the firm’s USPTO Trials & Post-Grant Proceedings group, was quoted in “Some Consensus in the CRISPR Patent Case,” an article published in MedCity News. The article discuses four companies founded in the CRISPR space that announced last Friday, December 16, that they had formed an IP alliance.

Read the article here

 

Related Links

Industries

News & Insights

News
May 2026
Dan Gibson Discusses How AI, Cloud Gaming, and Games-as-a-Service Are Reshaping Patent Strategy in the Video Game Industry
In a recent feature by Parola Analytics, Knobbe Martens partner Dan Gibson shared insights on how intellectual property and patent strategy are evolving in the video game industry amid advances...
Blog - Energy
May 2026
Drilling for Gold: How the Next Geothermal Rush Is Creating a New Patent Battleground
Key Takeaways: Technological advancements in geothermal exploration and drilling are reducing uncertainty and lowering risk profiles, making private investors and lenders more willing to commit capital that was historically constrained...
Publications
May 2026
Kregg Koch Discusses How Medtech Innovators Can Build a Stronger IP Strategy Through Patent Filing, Portfolio Development, and AI
In an article published by nonprofit educational medtech incubator Fogarty Innovation, Knobbe Martens partner Kregg Koch shared practical strategies for medtech companies and entrepreneurs looking to protect and maximize the...